FABP7 and multiple system atrophy: Notably, a recent report demonstrated the ameliorative effects of an FABP7 inhibitor on oligodendrocyte injury in a mouse model of multiple sclerosis68 and on cerebellum dysfunction in a multiple-system atrophy mouse model69.